Synta Pharmaceuticals

Small molecule drugs for cancer and chronic inflammatory conditions

placeLexington, Massachusetts, United States calendar_todayFounded 2000 groups37 employees language syntapharma.com

Registered entities

Innovation

189 patent families (106 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace slowing. Cited 17,703 times.

YearFilings
201381
201478
201549
201621
201716
20185
20195
20202
20212
20222
20231
20241

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon